Dexcel Pharma - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeDexcel Pharma
Dexcel Pharma logo

Dexcel Pharma

0 followers

About Dexcel Pharma

Dexcel Pharma is a privately owned pharmaceutical company engaged in the development, manufacturing, and commercialization of innovative and generic drug products worldwide. The company emphasizes commitment to dream, develop, and deliver across therapeutic areas, with operations spanning research, manufacturing, and market access. Its global reach includes key markets in the United States, Israel, Germany, the United Kingdom, and Austria, supported by a diversified portfolio that includes branded prescription drugs, OTC products, and generics.

Recent News

Recent Deals

Key Team Members

Itamar Yaron-Enden

VP, Business Development

Uri Oren

Co-Chief Executive Officer

Ilan Oren

Co-Chief Executive Officer

Eyal Dayan

VP, Research & Development

Ygal Seelenfreund

VP, Sales & Marketing, International

Key Facts

HQ Location

Israel

Founded

1968

Employees

501-1K

Status

Investor

Investor Type

Corporate Investor

Website

https://dexcel.com